RNA-Targeted Small Molecules Market Overview
According to the latest research by Future Market Insights, RNA-Targeted Small Molecules market is set to witness a 6.6% growth during the year 2021-2031.
The market is a fragmented market growing at a slow rate and is anticipated to witness lucrative growth with the rising use of methodologies by major players; the market is projected to grow over the forecast period.
What is Driving Demand for RNA-Targeted Small Molecule
Factors such as development in genome mapping programs, the rising innovative developments, and increasing applications are anticipated to boost the market growth.
Moreover, technological advancements help in the market development. Technological developments has assisted analysts to collect vital information about public health and epidemiology studies, to sequence viruses and bacteria and help find causes that might add to the virulence.
Furthermore, the market is boosted by the advantages of rising number of mRNA-sequencing grants; mRNA-sequencing over traditional technologies; quick development in the precision medicine market; and increasing amount of research including RNA-seq.
Growing Number of Cancer Cases, likely to Boost RNA-Targeted Small Molecules Sales
Cancer is one of the leading cause of death across the world. As per the American Cancer Society, around 1.8 million new cancer cases were diagnosed and around 606,520 cancer deaths occurred in 2020, in the United States. Hence, rising burden of a wide range of diseases among people, worldwide, is expected to boost the demand for the market.
There has been an increase in the utilization of advanced technologies, like combinatorial chemistry, bioinformatics, and high throughput for better drug candidate detection.
US and Canada RNA-Targeted Small Molecules Market Outlook
The US and Canada RNA-Targeted Small Molecules market is projected to observe a robust growth in the market due to the rise in presence of several cancer-relief organizations and campaigns in the US and Canada.
In addition, US has high opportunities for biosimilars, because biologics hold higher price. By 2021, the US market is expected to be one of the main competitors of biosimilars.
Moreover, beneficial government initiatives and upsurge in number of research partnerships are few of the factors projected to upsurge market growth.
Europe Demand Outlook for RNA-Targeted Small Molecules
Europe is anticipated to be second most lucrative region for market due to various factors. The growing patient pool results into a high rate of RNA-targeted small molecules adoption due to the growing number of cancer patients.
In addition, rise in cancer patients, focus on merger and acquisition and funding by the governmental bodies by several major manufacturers is anticipated to lead to RNA-targeted small molecules market growth.
Who are the Key Manufacturers and Suppliers of RNA-Targeted Small Molecules
Some of the leading manufacturers and suppliers of RNA-Targeted Small Molecules include
- Bentham Science,
- Nymirum Inc.,
- Accent Therapeutics,
- Anima Biotech Inc.
- Expansion Therapeutics
- Bristol-Myers Squibb,
- Novartis and others.
The market is fragmented with presence of different major players. Technological collaborations and partnerships by the key players in the market with a vision to bridge the demand-supply gap is projected to play a major role in growth of the market.
Globally, they are involved in long term contracts with healthcare organizations, and are comprising into strategic alliances and partnerships with other players in several nations to expand their business. In addition, key manufacturers are funding extensively in the research and development to produce advanced products.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
By Product & Service:
- mRNA Translation Regulation
- Indirect RNA Targeting – Epitranscriptomics
- RNA Splicing Modification
- Direct RNA Targeting
- Drug Discovery
- Oncology Research
- Disease Identification
By End User:
- Research Laboratories
- Contract Research Organizations
- Pharmaceutical and Biotechnology Companies
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa